Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) EPS (Weighted Average and Diluted) (2017 - 2025)

Selectis Health's EPS (Weighted Average and Diluted) history spans 14 years, with the latest figure at $0.24 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 146.15% year-over-year to $0.24; the TTM value through Sep 2025 reached -$0.28, up 84.44%, while the annual FY2024 figure was -$0.8, 38.93% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was $0.24 at Selectis Health, up from -$0.1 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.32 in Q1 2023 and bottomed at -$1.2 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.22 (2025), against an average of -$0.2.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 4507.64% in 2021 before it tumbled 2300.0% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.64 in 2021, then dropped by 12.5% to -$0.72 in 2022, then crashed by 66.67% to -$1.2 in 2023, then surged by 83.33% to -$0.2 in 2024, then skyrocketed by 220.0% to $0.24 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's EPS (Weighted Average and Diluted) are $0.24 (Q3 2025), -$0.1 (Q2 2025), and -$0.22 (Q1 2025).